(Q46032921)

English

Prevalence of use and the risk of adverse effects associated with complementary and alternative medicine in a cohort of patients receiving warfarin.

scientific article published on 28 April 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19401475

Prevalence of use and the risk of adverse effects associated with complementary and alternative medicine in a cohort of patients receiving warfarin. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19401475

author name string

Vivian W Y Leung

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19401475

Stephen J Shalansky

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19401475

Melissa K Lo

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19401475

Esther A Jadusingh

4

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19401475

language of work or name

0 references

publication date

28 April 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19401475

Annals of Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19401475

43

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19401475

5

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19401475

875-881

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19401475

Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L631

21 January 2018

Risk of warfarin-related bleeding events and supratherapeutic international normalized ratios associated with complementary and alternative medicine: a longitudinal analysis

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L631

21 January 2018

An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L631

21 January 2018

Frequency and causes of overanticoagulation and underanticoagulation in patients treated with warfarin

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L631

21 January 2018

Complimentary and alternative medicine use among patients starting warfarin

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L631

21 January 2018

Drug interactions update: drugs, herbs, and oral anticoagulation

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L631

21 January 2018

Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L631

21 January 2018

Potential interactions between complementary/alternative products and conventional medicines in a Medicare population

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L631

21 January 2018

Use of alternative medicine by patients undergoing cardiac surgery

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L631

21 January 2018

The use of complementary and alternative therapies among middle-aged and older cardiac patients.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L631

21 January 2018

Use of complementary and alternative medical therapies in patients with cardiovascular disease

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L631

21 January 2018

The cardiovascular patient's perceptions of complementary and alternative medicine

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L631

21 January 2018

Systematic overview of warfarin and its drug and food interactions

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L631

21 January 2018

Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L631

21 January 2018

Herb-drug interactions

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L631

21 January 2018

Safety issues with herbal medicine

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L631

21 January 2018

Herb-drug interactions: an evidence based approach

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L631

21 January 2018

Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L631

21 January 2018

Risk factors for intracranial hemorrhage in outpatients taking warfarin

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L631

21 January 2018

Use of herbal medicines by patients receiving warfarin.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L631

21 January 2018

Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L631

21 January 2018

Lack of herbal supplement characterization in published randomized controlled trials

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L631

21 January 2018

Factors associated with dietary supplement use among prescription medication users

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L631

21 January 2018

Complementary and alternative medicine (CAM) use by older adults: a comparison of self-report and physician chart documentation

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L631

21 January 2018

U.S. and Canadian pharmacists' attitudes, knowledge, and professional practice behaviors toward dietary supplements: a systematic review

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L631

21 January 2018

Use of OTC and Herbal Products in Patients with Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L631

21 January 2018

Identifiers

10.1345/APH.1L631

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19401475

release_aczrkl7strgcbpoz3jyst6dfom

1 reference

https://api.fatcat.wiki/v0/release/aczrkl7strgcbpoz3jyst6dfom

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19401475

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46032921&oldid=2158627492"